Patent details

Basic Information

Publication number:

EP2001838

PCT Application Number:

PCT/US/2007/064973

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP077594216

PCT Publication Number:

WO/2007/117981

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

SELECTIVE HYDROXAMATE BASED MMP INHIBITORS

French Title of Invention:

INHIBITEURS DE MMP SELECTIFS A BASE D'HYDROXAMATE

German Title of Invention:

SELEKTIVE MMP-HEMMER AUF HYDROXAMATBASIS

SPC Number:

Dates

Filing date:

27/03/2007

Grant date:

12/03/2014

EP Publication Date:

12/03/2014

PCT Publication Date:

18/10/2007

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

17/12/2008

EP B1 Publication Date:

12/03/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

27/03/2014

Expiration date:

27/03/2027

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

27/03/2007

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Name:

Novartis Pharma GmbH

Address:

Brunner Strasse 59, 1230 Wien, Austria (AT)

Inventor

1

Name:

PUSATERI Erin, E.

Address:

United States (US)

2

Name:

HONDA Ayako

Address:

United States (US)

3

Name:

LEUTERT Thomas

Address:

Switzerland (CH)

4

Name:

GROB Jonathan, E.

Address:

United States (US)

5

Name:

TOMMASI Ruben, Alberto

Address:

United States (US)

Priority

Priority Number:

786891 P

Priority Date:

29/03/2006

Priority Country:

United States (US)

Classification

Main IPC Class:

C07C 311/19;

Filing date	Document type	Number of pages